TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Acceptability of support tool
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of support tool
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Medication Rescue
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in IKDC Subjective Knee Evaluation Form Score at Month 6 Post-Operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in IKDC Subjective Knee Evaluation Form Score at Month 12 Post-Operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Visual Analogue Scale (VAS) - Pain Score at Month 6 Post-Operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: iAUC of EPA+DHA from 0 to 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Speech reception threshold (SRT) in noise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of Alcohol Use during Ecological Momentary Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past 30-day Alcohol Use during Follow-Up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until opportunistic infection treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: number of participants with good re-perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary oxalate and glycolate excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Colorectal Cancer Screening Completion Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent Stress Index (PSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dyadic Parent-Child Interaction Coding System
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Difficult Puzzle Lab Task - Early Parenting Coding System (EPCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Behavioral Therapy Parent Quiz
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total amino acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endothelial nitric oxide synthase levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hypoglycemia fear behavioral
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hypoglycemia fear worry
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Electrical Sensation Mapping Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changed symptoms specific for OAB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of general anesthesia induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Characterization of device-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in back and leg pain Visual Analog Score (VAS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in elastography features of the myofascial unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants with the lived experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Surgical management of bladder tear
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-transplant Neurological Complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electrodermal activity in response to sensory stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of progressive motile sperm (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in acne lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: IPAQ- quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VSAQ-exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and proportion of subjects with a treatment-related TEAE
Endpoint domain: Adverse events/effects
Primary endpoint: Number and proportion of subjects who experience a serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number and proportion of subjects who experience a treatment-related Grade 3 or 4 TEAE
Endpoint domain: Adverse events/effects
Primary endpoint: Resection margin involvement (R1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percent of Wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross Motor Function Measure (GMFM)-88
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in insomnia episodes and symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Back Pain and Body Posture Assessment Instrument total score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Accuracy of the IVC Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neopterin Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale (VAS) (Sitting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) (Resting)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) (Movement)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of 177Lu-DOTATATE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Translational head motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rotational head motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Head deformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unacceptable toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Endothelial Progenitor Cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: trimethylamine N-oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: multidimensional (MDP) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sensory Borg scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: affective Borg scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of Life - BREF (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Freedom from Arterial Hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from System-related Major Adverse Events (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Montreal Cognitive Assessment Test for Dementia (MoCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amyloid PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Detecting drop errors (DEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Composite disorientation score (CDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measurement of organoid's response to therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validation of patient's response to therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison between organoid's and patient's response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month overall survival (OS) rate
Endpoint domain: Mortality/survival
Primary endpoint: 9-month overall survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: EEG band power (alpha, beta, delta and theta bands)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress hormone levels: Salivary cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change from Baseline Brief Pain Inventory (BPI) Interference Scale at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Improvement or maintenance of oral feeding and/or absence of GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of Continuous Beta-Agonist Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Geographic Atrophy area (mm2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-12 Hz modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in blood glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to cardiovascular death, stroke, myocardial infarction (MI), or urgent arterial
Endpoint domain: Mortality/survival
Primary endpoint: Time to major bleeding according to the International Society of Thrombosis and Hemostasis classification
Endpoint domain: Adverse events/effects
Primary endpoint: Hospitalization for respiratory infections
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Maximum Observed Serum Concentration (Cmax) for Multiple Ascending Dose of ABBV-916
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brain Amyloid Plaque Deposition (Amyloid Centiloid Value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Re-hospitalization due to heart decompensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-cholecystectomy complications
Endpoint domain: Adverse events/effects
Primary endpoint: Exponential rate of change in serum potassium levels during the acute treatment phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Exponential rate of change in serum potassium levels during the maintenance treatment phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Incidence of Stroke or TIA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Local Field Potentials during Cognitive Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Trail Making Test A & B
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: N-Back Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Airway Compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Intrahospital Major Vascular Complications and Bleeding type 2 or type >2
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of successful femoral closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knowledge of skin of color clinics/training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance to quality indicator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of patients achieving target Hb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in Pain Detection Thresholds (PDTs) for the UVB Heat Pain Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Pain Detection Thresholds (PDTs) for the Capsaicin Heat Pain Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Area of Secondary Mechanical Allodynia After the Capsaicin Challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Pain Tolerance Thresholds (PTTs) for the Cold Pressor Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calf Muscles Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait Mechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported pain, and injury
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change from baseline in behavior problems (parent-ratings)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in anger (child-ratings)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of eligible patients consenting to participate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of patients adhering to the study protocol in terms of medication intake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of patients completing their outcome (self-)assessments (i.e. questionnaires)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of patients' satisfaction with the intervention and study procedure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gagging Preventive Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Home-testing Kit Completion
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Pressure Injury Risk Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Yale-Brown Obsessive-Compulsive Scale (YBOCS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hamilton Depression Inventory (HAM-D) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence or recurrence of sialoadenitis
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular disease detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Change in Subjective Well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Change in Autonomy Ratings
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mean Change in Competence Ratings
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mean Change in Relatedness Ratings
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Incidence and severity of hematological adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Ability to Successfully Obtain Sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: genetic screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biomarker assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference of cellular inorganic phosphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference of cellular phosphocreatine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference of intracellular pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rhinomanometry Measurement Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Polygraphy Measurement Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Product initial attitudes rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Product satisfaction rating
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adherence to study product regimen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sensitivity and precision of the scratching algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Documentation of Access to Firearms
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent Change in Documentation of Counseling on Firearm Injury Prevention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Adverse Events Using the Common Terminology Criteria for Adverse Events (CTCAE) v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adverse Events Using the Clavien-Dindo Classification System
Endpoint domain: Adverse events/effects
Primary endpoint: Average Time for Participants to Return to Potency - Sexual Health Inventory for Men (SHIM) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Average Time to Return to Bladder Control/Urinary Continence - ICIQ-UI Short Form
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Valve damage indicative sign
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Nasal Congestion/Obstruction Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment to target
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in orthostatic hypotension questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preservation or improvement of inner ear auditory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus symptom relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilator free days (VFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total number of mRNA copies from HEEC culture of tPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total number of mRNA copies from HEEC culture of PAI-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total number of mRNA copies from HEEC culture of TFPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in the numerical score of Pictorial Blood Loss Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patients' satisfaction: BREAST-Q score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health-related quality of life: EORTC QLQ-BR23
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Subjects Free from Acute Aveir VR System-Related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Free from Chronic Aveir VR System-Related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: 1 year arrhythmia recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete response (CR) rate at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Had penis-in-vagina sex in the last three months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FGF21 incremental area-under-the-curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of participants with verified continuous smoking abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: height of the periimplant bone tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: height of the periimplant soft tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unique brain electrical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increase in numbers of walk in patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Pathological complete response (tpCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-vaccination frequency of seroconversion of type 1 anti-polio serum neutralizing antibody (NAb)
Endpoint domain: Adverse events/effects
Primary endpoint: Eating Disorder Examination - Self-Report Questionnaire (EDE-Q)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Impairment Assessment (CIA)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Body Shape Questionnaire (BSQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of participants below the clinical cut off for problematic anger
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of participants with decreased hostile interpretation bias scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing